Studies
Study First Submitted Date | 2021-03-30 |
Study First Posted Date | 2021-04-22 |
Last Update Posted Date | 2022-05-06 |
Verification Month Year | December 2020 |
Verification Date | 2020-12-31 |
Last Update Posted Date | 2022-05-06 |
Conditions
Sequence: | 51749019 |
Name | Alzheimer Disease |
Downcase Name | alzheimer disease |
Id Information
Sequence: | 39821839 |
Id Source | org_study_id |
Id Value | CTXSP0001 |
Interventions
Sequence: | 52070737 |
Intervention Type | Drug |
Name | Adipose-Derived Mesenchymal Stem Cells |
Keywords
Sequence: | 79176597 |
Name | Autologous Adipose-derived Stem Cells (AdMSCs) |
Downcase Name | autologous adipose-derived stem cells (admscs) |
Browse Conditions
Sequence: | 191786132 | Sequence: | 191786133 | Sequence: | 191786134 | Sequence: | 191786135 | Sequence: | 191786136 | Sequence: | 191786137 | Sequence: | 191786138 | Sequence: | 191786139 | Sequence: | 191786140 |
Mesh Term | Alzheimer Disease | Mesh Term | Dementia | Mesh Term | Brain Diseases | Mesh Term | Central Nervous System Diseases | Mesh Term | Nervous System Diseases | Mesh Term | Tauopathies | Mesh Term | Neurodegenerative Diseases | Mesh Term | Neurocognitive Disorders | Mesh Term | Mental Disorders |
Downcase Mesh Term | alzheimer disease | Downcase Mesh Term | dementia | Downcase Mesh Term | brain diseases | Downcase Mesh Term | central nervous system diseases | Downcase Mesh Term | nervous system diseases | Downcase Mesh Term | tauopathies | Downcase Mesh Term | neurodegenerative diseases | Downcase Mesh Term | neurocognitive disorders | Downcase Mesh Term | mental disorders |
Mesh Type | mesh-list | Mesh Type | mesh-ancestor | Mesh Type | mesh-ancestor | Mesh Type | mesh-ancestor | Mesh Type | mesh-ancestor | Mesh Type | mesh-ancestor | Mesh Type | mesh-ancestor | Mesh Type | mesh-ancestor | Mesh Type | mesh-ancestor |
Sponsors
Sequence: | 47926977 |
Agency Class | INDUSTRY |
Lead Or Collaborator | lead |
Name | Celltex Therapeutics Corporation |
Overall Officials
Sequence: | 29038871 |
Role | Principal Investigator |
Name | Richard L Neel, M.D. |
Affiliation | Little Alsace Urgent Care Center |
Eligibilities
Sequence: | 30518936 |
Minimum Age | N/A |
Maximum Age | N/A |
Criteria | Inclusion Criteria: The patient is diagnosed with later stage of Alzheimer Disease with sever cognitive disability. All current anti-Alzheimer medicines cannot prevent disease progression and the patient's mental and physical ability persistently declined Patient's legal guardian and caregiver must voluntarily sign an approved written consent form after ample explanation of the proposed therapy. Exclusion Criteria: Current diagnosis of malignancy Renal/liver dysfunction: Exceed two times as normal subject Pregnant or nursing Received other trial drugs within 30 days after participation of this study Experienced major surgery or trauma in the last 14 days |
Adult | True |
Child | True |
Older Adult | True |
Calculated Values
Sequence: | 254075410 |
Registered In Calendar Year | 2021 |
Were Results Reported | False |
Has Single Facility | False |
Responsible Parties
Sequence: | 28648149 |
Responsible Party Type | Sponsor |